[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-350107-en":59,"doc-seo-350107-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},350107,962084928432,"Maya Linwood","https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Immune Escape in Renal Cell Carcinoma - Latest Research and Treatment Strategies","Renal cancer is a common malignant tumor in the urinary system. Current research shows that immune escape in kidney cancer prevents immune system attacks through specific mechanisms, allowing cancer cells to survive, leading to progression and metastasis. Despite rapid immunotherapy advances, high recurrence, drug resistance, and severe side effects remain unresolved. This review compiles current immune-escape mechanisms in the renal cancer immune microenvironment and summarizes emerging treatment strategies targeting them.","Review  \nImmune Escape in Renal Cell Carcinoma: Latest Research and Treatment Strategies  \nKaixiang Huang and Ke Chen *  \nAcademic Editor: Stergios Boussios  \nReceived: 16 February 2026  \nRevised: 18 March 2026  \nAccepted: 21 March 2026  \nPublished: 27 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430100, China; [kxiang0303@163.com](kxiang0303@163.com)  \n* Correspondence: [kechen@hust.edu.cn](kechen@hust.edu.cn); Tel.: +86-02783663460  \nAbstract  \nRenal cancer is a common malignant tumor in the urinary system. Current research has found that immune escape in kidney cancer can prevent immune system attacks through specific mechanisms, making it difficult for the immune system to effectively kill cancer cells, and promote the progression and metastasis of kidney cancer. Therefore, despite the continuous updating of immunotherapy methods for kidney cancer, the high recurrence rate, high drug resistance, and severe side effects of kidney cancer patients are still difficult to solve. This review systematically summarizes the latest mechanisms of immune escape in the renal cancer immune microenvironment, including abnormal expression of histocompatibility complex (MHC), secretion of immunosuppressive factors, programmed death ligand-1 with abnormal expression, recruiting immunosuppressive cells, and VHL gene deletion. This article also summarizes new treatment strategies proposed for these immune escape mechanisms. We hope this will help future researchers further explore the immune escape mechanism of renal cell carcinoma and propose new immunotherapy strategies.  \nKeywords: renal cancer; immune escape; MHC-1; PD-L1; VHL  \n1. Introduction  \nRenal cancer constitutes roughly 3% of all malignant neoplasms. The incidence rate of renal cancer ranks the third among urinary system tumors [1] . The annual occurrence rate of RCC (renal cell carcinoma) is increasing. Given the absence of distinctive earlystage symptoms, the majority of cases are detected during routine physical exams and are prone to being overlooked. When obvious symptoms such as hematuria, lower back pain, and abdominal masses appear, the condition has often progressed to the middle and late stages [2] . Renal cancer is insensitive to chemotherapy and radiotherapy, and the effectiveness of traditional treatment methods is very limited [3] . Late-stage patients rely on targeted therapy (such as sorafenib, sunitinib) or immunotherapy (such as PD-1 inhibitors) but are prone to developing drug resistance [4] . Renal cancer and immunity have a bidirectional regulatory relationship. Due to the immune monitoring function of the immune system, abnormal cells can be eliminated early to prevent cancer, while renal cancer weakens immune defense through immune escape mechanisms and can even promote tumor progression [5] . Despite extensive research on how kidney cancer can avoid immune damage, discovering effective immunotherapy remains a daunting task for researchers and clinical doctors. It is crucial to systematically study the immune escape mechanism of renal cell carcinoma to improve the effectiveness of immunotherapy and  \nreduce drug resistance. The new targets for immunotherapy of kidney cancer need to be promoted simultaneously in both basic and clinical trials, and the combination therapy can bring more hope to kidney cancer patients. In this article, we systematically outline the immune escape mechanism of RCC, with a focus on the latest research progress and corresponding new treatment strategies.  \n2. Overview of the Immune Microenvironment in Renal Cancer  \nIn the progression of tumors, the immune microenvironment of tumors cannot be ignored. The interactive environment formed by immune","cbCaiv5VF0SG4PkZ","https://ap.wps.com/l/cbCaiv5VF0SG4PkZ","pdf",2934229,21,"English","en",105,"# Introduction\n# Overview of the Immune Microenvironment in Renal Cancer","[{\"question\":\"How does immune escape contribute to renal cell carcinoma progression?\",\"answer\":\"Immune escape mechanisms weaken immune surveillance so cancer cells are not effectively eliminated. This facilitates tumor progression and metastasis.\"},{\"question\":\"What immune-escape mechanisms does the review summarize?\",\"answer\":\"The review summarizes mechanisms in the renal cancer immune microenvironment, including abnormal MHC expression, immunosuppressive factor secretion, PD-L1 abnormalities, recruitment of immunosuppressive cells, and VHL gene deletion.\"},{\"question\":\"Why is developing effective immunotherapy still difficult for renal cancer?\",\"answer\":\"Renal cancer has limited responsiveness to chemotherapy and radiotherapy, and late-stage disease frequently develops drug resistance to targeted or immune-based therapies. Effective immunotherapy targets still require systematic discovery and validation.\"}]","Immune Escape in Renal Cell Carcinoma - Latest Research and Treatment Strategies | PDF",1790087208,53,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c95c50fad2849b1ef4e0882be910ec85.webp",983,1390,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee5c89194b1e62dd4351e72dfd89242e.webp",982,1388,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14cee5e8c891ade44a57d69ce050a7f0.webp",981,1387,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cf4eed004bcc136a0a94fff2157f640.webp",980,1385,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"immune-escape-in-renal-cell-carcinoma-latest-research-and-treatment-strategies","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/immune-escape-in-renal-cell-carcinoma-latest-research-and-treatment-strategies/350107/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/immune-escape-in-renal-cell-carcinoma-latest-research-and-treatment-strategies/350107.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":24},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"How does immune escape contribute to renal cell carcinoma progression?","Question",{"text":146,"@type":147},"Immune escape mechanisms weaken immune surveillance so cancer cells are not effectively eliminated. This facilitates tumor progression and metastasis.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"What immune-escape mechanisms does the review summarize?",{"text":151,"@type":147},"The review summarizes mechanisms in the renal cancer immune microenvironment, including abnormal MHC expression, immunosuppressive factor secretion, PD-L1 abnormalities, recruitment of immunosuppressive cells, and VHL gene deletion.",{"name":153,"@type":144,"acceptedAnswer":154},"Why is developing effective immunotherapy still difficult for renal cancer?",{"text":155,"@type":147},"Renal cancer has limited responsiveness to chemotherapy and radiotherapy, and late-stage disease frequently develops drug resistance to targeted or immune-based therapies. Effective immunotherapy targets still require systematic discovery and validation.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790245268]